![Phillip Dennis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Phillip Dennis
Directeur Technique/Scientifique/R&D chez
NOVABRIDGE BIOSCIENCES
Fortune : 137 207 $ au 31/08/2026
Profil
Dr. Phillip Dennis is a Chief Medical Officer at NovaBridge Biosciences and a Member at American Society for Clinical Investigation.
He received his graduate degree from New York University School of Medicine and a doctorate degree from New York University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/09/2026 | 173 427 ( 0,09% ) | 137 207 $ | 31/08/2026 |
Postes actifs de Phillip Dennis
| Sociétés | Poste | Début |
|---|---|---|
| NOVABRIDGE BIOSCIENCES | Directeur Technique/Scientifique/R&D | 17/06/2024 |
American Society for Clinical Investigation
 American Society for Clinical Investigation BiotechnologyHealth Technology Provides clinical investigation services | Corporate Officer/Principal | - |
Formation de Phillip Dennis
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
American Society for Clinical Investigation
American Society for Clinical Investigation BiotechnologyHealth Technology Provides clinical investigation services | Health Technology |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
I-Mab
 I-Mab Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer and autoimmune diseases | Health Technology |
